Bottom line
SCHLX vs RYHIX: the short answer
SCHLX (DWS Health and Wellness Fund) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 77% by weight.
But RYHIX is far broader, holding 135 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
SCHLX is cheaper at 1.06% vs 1.38% — a difference of $32 a year per $10,000 invested.
Updated Nov 19, 2026
SCHLX vs RYHIX side by side
| SCHLX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | DWS (Xtrackers) | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.06% | 1.38% |
| Annual cost per $10k | $106 | $138 |
| 10-yr cost on $10k (prospectus) | $1,294 | $1,709 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +14.4% |
| 5-yr return (annualized) | — | +5.1% |
| 10-yr return (annualized) | — | +7.9% |
| Best quarter | — | +18.7% |
| Worst quarter | — | −14.4% |
| Net assets (fund) | $231.8M | $19.4M |
| Number of holdings | 65 | 135 |
| Portfolio turnover | 2% | 244% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
20 of SCHLX's top 25 holdings also appear in RYHIX's top 25.
| Holding | SCHLX | RYHIX |
|---|---|---|
| Eli Lilly & Co | 13.85% | 3.63% |
| Johnson & Johnson | 6.19% | 2.88% |
| UnitedHealth Group Inc | 5.73% | 2.22% |
| AbbVie Inc | 4.90% | 2.52% |
| Merck & Co Inc | 4.85% | 2.04% |
| Thermo Fisher Scientific Inc | 3.46% | 1.61% |
| Amgen Inc | 2.88% | 1.56% |
| Gilead Sciences Inc | 2.78% | 1.39% |
| Intuitive Surgical Inc | 2.69% | 1.31% |
| Stryker Corp | 2.61% | 1.21% |
| Vertex Pharmaceuticals Inc | 2.45% | 1.34% |
| Abbott Laboratories | 2.39% | 1.42% |
| Danaher Corp | 2.13% | 1.30% |
| Boston Scientific Corp | 2.10% | 0.86% |
| McKesson Corp | 2.05% | 1.05% |
Source: SEC Form N-PORT
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between SCHLX and RYHIX?
Which is cheaper, SCHLX or RYHIX?
Should I own both SCHLX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.